Tradestie Institutional Equity Comparison Engine

AHD vs ACA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACA Overall Edge

ACA Captures Institutional Edge (4โ€“0 Pillars ยท 10โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcosa, Inc. Common Stock (ACA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AHD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ACA at 29.1x Forward P/E and 12.3% operating margin (+1.7% YoY). In options structure, AHD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ACA sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ACA
AHD N/M vs ACA 29.1x Fwd P/E
Growth & Margin Winner ACA
Op Margin N/A vs 12.3% ยท YoY N/A vs +1.7%
Momentum & Technical Winner ACA
1Y -11.9% vs +57.4% ยท 52W Pos 0% vs 100%
Options & Structure Winner ACA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
AHD US Equity
AHD
Institutional Equity
$21.81
-5.55% 1D
Market Cap N/A
1M Return -15.78%
1Y Return -11.92%
Forward P/E N/M
Unified AI Score
41.6 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 69.0
ACA NYSE
Arcosa, Inc. Common Stock
Fabricated Structural Metal Products
$149.15
+0.08% 1D
Market Cap $7.3B
1M Return +1.81%
1Y Return +57.43%
Forward P/E 29.1x
Unified AI Score
60.0 / 100 BUY
Tech 56.0 Fund 49.0 Flow 50.0 Mom 36.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AHD -11.92% ACA +57.43% Spread: +22.64 pp (ACA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AHD TTM Op. Margin: N/A ACA TTM Op. Margin: 12.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AHD vs ACA. Trailing 12-month operating profitability (AHD N/A vs ACA 12.3%) and valuation multiples (AHD N/M vs ACA 29.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AHD (0) vs ACA (10)
Institutional Metric AHD ACA Criterion Row Winner
Market Capitalization Scale N/A $7.3B Larger Scale ACA
Trailing P/E Ratio Valuation N/M 36.4x Lower Multiple ACA
Forward P/E Ratio Valuation N/M 29.1x Lower Multiple ACA
Revenue Growth (YoY) Growth N/A +1.7% Higher Growth ACA
Operating Margin (TTM) Profitability N/A 12.3% Higher Margin ACA
Net Profit Margin Profitability N/A 16.8% Higher Margin ACA
Return on Equity (ROE) Capital Efficiency N/A 8.0% Higher ROE ACA
52-Week Range Position Momentum 0% ($22โ€“$30) 100% ($91โ€“$149) Stronger Trend ACA
Beta / 30D Volatility Risk Regime 0.58ฮฒ ยท 26% Vol 0.92ฮฒ ยท 4% Vol Lower Realized Risk ACA
Unified Institutional Score Composite Signal 41.6 / 100 (SELL) 60.0 / 100 (BUY) Higher Composite ACA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AHD vs ACA Buy Guide
AHD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AHD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ACA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live ACA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AHD nor ACA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.